Tilray Inc. ($TLRY) Stock Forecast: Up 5.4% Today

What is Tilray Inc.?

Tilray Brands, Inc. (TLRY) is a leading cannabis company known for its innovative products and global presence. The overall market sentiment has been positive with a focus on growth and potential in the cannabis industry.

Why is Tilray Inc. going up?

TLRY stock is up 5.4% on Sep 18, 2025 18:06

• TLRY experienced a strong bullish movement despite registering a fall in the previous trading session.
• The bullish movement could be attributed to positive developments within the cannabis industry, such as potential legalization or strong earnings.
• Investors may be optimistic about TLRY's future, leading to increased buying activity and driving the stock price higher.
• Despite the recent fall, market participants seem confident in TLRY's long-term growth potential, fueling the observed bullish movement today.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands, Inc. ( TLRY ) Registers a Bigger Fall Than the Market: Important Facts to Note

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $1.19, moving 2.46% from the previous trading session.

https://www.zacks.com/stock/news/2753104/tilray-brands-inc-tlry-registers-a-bigger-fall-than-the-market-important-facts-to-note

Trending Today

Binance Coin ($BNB) Crypto Forecast: Up 5.0% Today

Avalanche ($AVAX) Crypto Forecast: Down 5.0% Today

Immutable ($IMX) Crypto Forecast: Down 6.2% Today

Polkadot ($DOT) Crypto Forecast: Down 5.4% Today

Chainlink ($LINK) Crypto Forecast: Down 5.0% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.4% Today

SoFi Technologies Inc. ($SOFI) Stock Forecast: Up 5.2% Today

Microsoft Corporation ($MSFT) Stock Forecast: Up 2.0% Today

Fiverr International Ltd. ($FVRR) Stock Forecast: Up 7.4% Today

Lemonda Inc. ($LMND) Stock Forecast: Up 5.5% Today

Tilray Inc. Price History

26.07.2025 - TLRY Stock was up 5.6%

• TLRY stock surged as the cannabis sector rallied, driven by increasing optimism for U.S. cannabis reform.
• Growing expectations for favorable regulatory changes in the U.S. cannabis market likely boosted investor sentiment towards TLRY.
• The positive market movement could also be attributed to a seasonal trading strategy outperforming the S&P 500, attracting more investors to cannabis stocks like TLRY.
• Overall, the bullish trend in TLRY reflects the sector's positive outlook and investor confidence in potential regulatory developments.

24.06.2025 - TLRY Stock was down 5.4%

• TLRY's stock saw a significant decline today, closing at $0.74, reflecting a -6.34% decrease compared to the previous day.
• The downward trend in the market may be linked to investor reactions concerning the possibly underwhelming Q4 earnings projections for Tilray Brands. Analysts are delving into estimations beyond financial figures such as revenue and EPS.
• While the overall market showed an increase, Tilray Brands, Inc. did not benefit from the positive movement, which could signal investor apprehensions regarding the company's current performance and future outlook.

15.08.2025 - TLRY Stock was up 5.3%

• TLRY stock had a strong bullish movement today despite the overall market uptick.
• The bullish movement could be attributed to Breckenridge Brewery receiving the Silver Certification for its sustainability practices, showcasing TLRY's commitment to environmental responsibility.
• The negative sentiment might be a short-term fluctuation or profit-taking by some investors, but the long-term outlook seems positive with the recent sustainability recognition.
• Investors may see TLRY as a socially responsible investment, which could have contributed to the bullish movement despite the temporary stock fall.

29.06.2025 - TLRY Stock was down 11.3%

• TLRY surpassed EPS estimates but fell short of revenue projections in its Q4 earnings report, resulting in a mixed investor response.
• The stock's decline could be linked to disappointment over missing revenue targets, despite exceeding expectations for earnings per share.
• Concerns about TLRY's future growth prospects and revenue performance may have prompted investors to sell off the stock.
• TLRY's lagging performance relative to the overall market uptrend may have led some traders to shift their attention to other income stocks that are thriving in the present market conditions.

29.06.2025 - TLRY Stock was down 14.5%

• Despite surpassing earnings per share (EPS) estimates in Q4, Tilray's stock witnessed a downward trend due to falling short on revenue predictions.
• Investor response indicates a higher value placed on revenue performance over the beat in EPS, signaling apprehensions regarding the company's future growth.
• The Q4 results, which were a mix of performance, are testing Tilray's efforts to turn around, underlining the significance of meeting revenue goals to maintain market trust.
• As Tilray's stock declines amid a bullish market, it highlights the unique obstacles the company is confronting, underscoring the necessity for a strong growth plan to reestablish investor confidence.

18.08.2025 - TLRY Stock was up 5.4%

• TLRY experienced a strong bullish movement despite registering a fall in the previous trading session.
• The bullish movement could be attributed to positive developments within the cannabis industry, such as potential legalization or strong earnings.
• Investors may be optimistic about TLRY's future, leading to increased buying activity and driving the stock price higher.
• Despite the recent fall, market participants seem confident in TLRY's long-term growth potential, fueling the observed bullish movement today.

13.07.2025 - TLRY Stock was up 15.1%

• Following discussions about the potential reclassification of marijuana by President Trump, TLRY stock saw a notable uptrend.
• The partnership between FL Group and Molteni aimed at broadening access to medical cannabis in Italy was another factor contributing to the positive market sentiment towards Tilray, hinting at growth prospects in overseas markets.
• With an increase in education among physicians in pain and dependency management, Tilray's credibility and market position are likely to improve, instilling confidence among investors in the company's stock.

18.07.2025 - TLRY Stock was up 6.0%

• Tilray's stock surged by 14.13% after hours following information about President Trump considering reclassifying marijuana, indicating potential positive implications for the industry.
• The company's request for more time from Nasdaq to meet listing standards and forming new partnerships in Italy to expand medical cannabis access have likely generated investor optimism.
• Partnerships with FL Group and Molteni to boost medical cannabis access and physician education in Italy could be seen as strategic moves, contributing to the bullish sentiment surrounding Tilray.
• Overall, the combination of positive industry information and strategic partnerships has likely fueled the strong bullish movement in Tilray's stock today.

28.07.2025 - TLRY Stock was up 5.8%

• Expanded its German medical marijuana lineup with three EU-GMP strains, boosting investor confidence in its growth prospects.
• Successfully regained compliance with Nasdaq's minimum bid price requirement, alleviating concerns about its listing status.
• Overall cannabis sector experienced a rally driven by optimism for U.S. cannabis reform, lifting Tilray's stock along with other industry peers.
• The positive news and market sentiment surrounding Tilray contributed to the bullish movement in its stock price today.

28.07.2025 - TLRY Stock was up 6.3%

• Regained compliance with Nasdaq's minimum bid price requirement, which boosted investor confidence in TLRY's financial stability.
• The overall bullish movement in the cannabis sector, supported by growing optimism for U.S. cannabis reform, led to a surge in Tilray's stock price.
• The company's adherence to regulations and positive sector sentiment likely drove TLRY's significant upward movement recently.

12.07.2025 - TLRY Stock was up 44.4%

• TLRY stock jumped by 14.13% after hours due to speculation about potential reclassification of marijuana by the government, signaling a promising future for the industry.
• Investors reacted optimistically to the news of marijuana possibly being reclassified, leading to a surge in Tilray's stock price.
• This development highlights the considerable impact that regulatory decisions can have on the performance of cannabis companies like Tilray.
• The bullish movement in TLRY demonstrates the market's responsiveness to regulatory changes that could affect the cannabis sector.

14.07.2025 - TLRY Stock was down 5.2%

• Tilray's application for an extension from Nasdaq to meet listing requirements might have sparked worries among investors regarding the company's adherence to standards and financial stability, resulting in a bearish atmosphere.
• While the collaboration with FL Group and Molteni to enhance medical cannabis availability in Italy was viewed positively, it may not have fully counteracted the broader market dynamics impacting the stock's descent.
• Although Tilray exhibited a surge in post-market trading post reports of potential cannabis reclassification by President Trump, the general market sentiment during regular trading hours may have been swayed by various other factors, contributing to the downtrend.